Argo Blockchain
ARBK
Strategy
MSTR
BTCS Inc
BTCS
Canaan
CAN
Bit Origin
BTOG
US Stock MarketDetailed Quotes
DRUG Bright Minds Biosciences
- 41.8000
- -3.9200-8.57%
Close Feb 14 16:00 ET
- 41.8000
- 0.00000.00%
Post 20:01 ET
294.44MMarket Cap-91.07P/E (TTM)
46.7151High40.3047Low79.52KVolume44.9300Open45.7200Pre Close3.42MTurnover3.56%Turnover RatioLossP/E (Static)7.04MShares79.020052wk High75.45P/B93.31MFloat Cap0.930052wk Low--Dividend TTM2.23MShs Float79.0200Historical High--Div YieldTTM14.02%Amplitude0.9300Historical Low43.0190Avg Price1Lot Size
Bright Minds Biosciences News
Bright Minds Biosciences | 6-K: Report of foreign private issuer (related to financial reporting)
Bright Minds Biosciences Shows Financial Improvement in Latest Report
Express News | Bright Minds Biosciences 13G Filing Shows Janus Henderson Group Reported A 11.6% Stake In The Co As Of January 31, 2025
Express News | Bright Minds Biosciences Inc Files for Offering of up to 1.6 Mln Common Shares by the Selling Securityholders - SEC Filing
HHS Secretary Nominee RFK Jr. Faces Contentious Senate Hearing
This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
Piper Sandler Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $93
Bright Minds Biosciences Initiated at Overweight by Piper Sandler
Piper Sandler Initiates Bright Minds Biosciences(DRUG.US) With Buy Rating, Announces Target Price $93
Yasmeen Rahimi's Buy Rating on Bright Minds Biosciences Driven by Promising Potential of BMB-101 for Epilepsy Treatment
Psychedelic Drug Developer Lykos Could Get Lifeline From Former Tesla Board Member
Cantor Fitzgerald Initiates Bright Minds Biosciences(DRUG.US) With Buy Rating
Cantor Fitzgerald Initiates Bright Minds Biosciences With Overweight Rating
H.C. Wainwright Initiates Bright Minds Biosciences(DRUG.US) With Buy Rating, Announces Target Price $85
Bright Minds Biosciences Appoints Stephen Collins as Chief Medical Officer
Express News | Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.d., Ph.d., as Chief Medical Officer
Bright Minds Biosciences | 20-F: FY2024 Annual Report
Bright Minds Biosciences (DRUG) Finishes the Year With Phenomenal Share Price Increase
Bright Minds Initiated at Outperform by Baird, Longboard Takeover Cited
Baird Initiates Bright Minds Biosciences(DRUG.US) With Buy Rating, Announces Target Price $75
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.